DESCRIPTION: (Applicant's Abstract)
The opiate analgesic drug morphine (MOR) has been shown to relieve pain by
mechanisms that include the release of neuronal histamine (HA) and the
subsequent activation of HA receptors in the periaqueductal grey (PAG). HA
is known to function as a neuromodulator substance in the central nervous
system. The proposed studies will characterize the sites and mechanisms by
which HA relieves pain, and search for novel, pain-relieving medications
based on these mechanisms. The experiments will use the techniques of in
vivo microdialysis, intracerebral injections, and nociceptive testing in
rats. The following studies will be performed: 1) MOR increases the
release of neuronal HA in the PAG. To determine the mechanisms of this
response, the effects of selective opiate receptor agonists and antagonists
will be studied on the release of HA in the PAG in vivo. 2) HA injections
into the PAG induce pain-relieving (i.e. analgesic) responses and, at higher
doses, pain-enhancing (i.e. hyperalgesic) responses. To discover the
pharmacological mechanisms underlying the HA-induced changes in nociceptive
threshold, the effects of selective HD agonists and HA antagonists will be
studied after intracerebral administration into the PAG. The unique HA-like
compound SKF92374 will also be studied, since this agent appears to induce
analgesic, but not hyperalgesic responses by a previously undiscovered
mechanism. 3) HA and MOR interact to produce synergistic analgesic
responses. To characterize the nature of these interactions, quantitative
antinociceptive studies will be performed with combinations of various doses
of HA and MOR. In addition, the effects of antagonists selective for
sub-types of opiate receptors and HA receptors will be studied on these
responses in the presence of these MOR-HA combinations. In addition to
these studies of the PAG, pilot studies suggest that HA may also be an
antinociceptive mediator in the raphe magnus (RM, another brain stem
structure known to be important in pain relief). To address this
hypothesis, several of the experiments proposed above for the PAG will also
be performed in the RM. These studies will clarify the mechanisms by which
MOR relieves pain, enhance the understanding of histaminergic
antinociceptive mechanisms, and may lead to the discovery of non-addicting,
novel medications for the treatment of pain.
No Sub Projects information available for 2R01DA003816-11A3
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01DA003816-11A3
Patents
No Patents information available for 2R01DA003816-11A3
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01DA003816-11A3
Clinical Studies
No Clinical Studies information available for 2R01DA003816-11A3
News and More
Related News Releases
No news release information available for 2R01DA003816-11A3
History
No Historical information available for 2R01DA003816-11A3
Similar Projects
No Similar Projects information available for 2R01DA003816-11A3